U.S. market Closed. Opens in 2 days 55 minutes

AYTU | Aytu BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-08-312014-06-302013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-31
Revenue81.00M107.40M96.67M65.63M27.63M7.32M3.66M3.22M2.56M261.78K1.00K58.93K1.75K1.75KN/AN/A1.75KN/AN/A
Cost of Revenue26.42M40.77M44.39M36.43M7.55M2.20M2.05M1.42M957.08K88.11KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit54.59M66.63M52.28M29.20M20.08M5.12M1.61M1.80M1.61M173.67KN/A58.93KN/A1.75KN/AN/A1.75KN/AN/A
Operating Expenses57.48M78.96M88.39M67.44M41.01M21.96M19.45M20.66M15.81M7.81M58.49K6.41M54.16K58.11K133.62K56.74K57.57K54.98K46.89K
Selling, General & Admin49.47M70.08M69.88M55.81M34.80M19.24M17.73M17.61M8.83M4.38M53.60K2.35M47.98K58.11K129.37K54.16K54.86K54.98KN/A
Research & Development2.79M4.09M14.44M5.62M1.72M589.07K167.59K1.35M6.32M3.42MN/A4.06MN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses568.00K-4.78M4.07M6.01M4.49M2.14M6.28M1.71M664.71KN/A4.89KN/A6.18KN/A4.25K2.58K2.71KN/A46.89K
Operating Income-5.25M-17.07M37.22M-38.24M-20.94M-16.85M-19.70M-20.13M-14.20M-7.63M-57.49K-6.35M-52.41K-56.36K-133.62K-56.74K-55.82K-54.98K-46.89K
Other Expenses / Income-6.39M-4.72M-147.50M-19.79M7.31M-10.29M8.41M-2.38M-13.98M-114.99K-4.23K-45.55K-4.90KN/AN/A274.00N/AN/AN/A
Before Tax Income-14.08M-17.05M-110.28M-58.03M-13.62M-27.13M-10.19M-22.51M-28.18M-7.75M-61.72K-6.39M-57.32KN/AN/AN/AN/AN/AN/A
Income Tax Expenses1.77M-57.00K-110.00K259.00K-9.92M20.04M-2.13MN/AN/A-23.91KN/A-813.70KN/AN/AN/AN/AN/AN/AN/A
Net Income-15.84M-17.05M-108.78M-58.29M-13.62M-47.17M-10.19M-22.51M-28.18M-7.72M-61.72K-5.58M-57.32K-59.67K-136.80K-60.27K-58.89K-57.17K-48.95K
Interest Expenses4.79MN/A147.50MN/AN/AN/A749.42K2.53M5.49M114.99K4.23K45.55K4.90K3.32K3.18K3.80K3.07KN/A2.06K
Basic Shares Outstanding5.54M3.34M1.47M840.00K230.00K38.97K3.33K2.33K935.00297.009.009.008.008.008.006.005.005.005.00
Diluted Shares Outstanding5.54M3.34M1.47M840.00K230.00K38.97K3.33K2.33K935.00297.009.009.008.008.008.006.005.005.005.00
EBITDA5.95M-7.60M41.28M-14.49M-24.61M-4.37M-8.98M-15.61M-21.81M-7.51M-52.71K-6.25M-47.47K-50.21K-126.86K-47.56K-47.54K-47.47K-40.47K
EBITDA Margin7.35%-7.07%42.70%-22.08%-89.07%-59.69%-245.22%-484.46%-851.29%-2,870.37%-5,270.90%-10,604.89%-2,712.69%-2,868.91%0.00%0.00%-2,716.51%0.00%0.00%
EBIT-9.28M-17.11M38.61M-58.03M-23.54M-27.13M-11.57M-19.97M-22.69M-7.63M-57.49K-6.35M-52.41K-56.36K-133.62K-56.47K-55.82K-57.17K-46.89K
EBIT Margin-11.46%-15.93%39.94%-88.42%-85.19%-370.64%-316.02%-619.92%-885.43%-2,915.53%-5,748.90%-10,770.31%-2,995.09%-3,220.34%0.00%0.00%-3,189.83%0.00%0.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-08-312014-06-302013-08-312012-08-312011-08-312010-08-312009-08-312008-08-312007-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙